Protein | Method of Identification | Cellular Context | Direct | Constitutive/Induced | Site of Interaction | Role | Reference | |
---|---|---|---|---|---|---|---|---|
CXCR4-interacting proteins | ||||||||
Filamin A | Pull-down | HEK293 cells | Yes | Constitutive and CXCL12-induced The ROCK inhibitor Y27632 reverses CXCL12-induced increased interaction | C-terminal tail and third loop of CXCR4 | Stabilize CXCR4 at the surface | Gómez-Moutón et al. (2015) | |
Co-IP | Recombinant protein | |||||||
AIP4 | Pull Down | HEK293 cells | Yes | Constitutive and CXCL12-induced | CXCR4 C-tail serines and WW domains of AIP4. Serine 324 and 325 when phosphorylated increase interaction | Increase CXCR4 degradation | Bhandari et al. (2009) | |
Co-IP | ||||||||
FRET | ||||||||
RTN3 | Y2H | HEK293 cells | NA | Constitutive, induction not tested | Carboxyl terminal of RTN3 | Increase cytoplasmic localization of CXCR4 | Li et al. (2016) | |
Co-IP | ||||||||
CD74 | Co-IP | HEK293 and MonoMac6 cells | NA | Constitutive, induction not tested | NA | Phosphorylation of AKT | Schwartz et al. (2009) | |
Colocalization | ||||||||
TLR2 | FRET | Human monocyte and HEK293 cells | NA | Induced by Pg-fimbria | NA | CXCR4 inhibits TLR2-induced NF- κB activation. In addition, CXCR4 found to be receptor of the pattern-recognition receptor complex | Hajishengallis et al. (2008), Triantafilou et al. (2008) | |
Co-IP | ||||||||
NMMHC | Pull-down | Jurkat T and Peer T cells lymphocytes | NA | Constitutive and not induced by CXCL12 | CXCR4 C-terminus | Lymphocytes migration | Rey et al. (2002) | |
Co-IP | ||||||||
Colocalization | ||||||||
Drebrin | Pull Down | J77 T, | YES | Constitutive and induced by superantigen E, which also relocalizes the interaction to the leading edge of migrating lymphocytes | Drebrin | Drebrin affects key physiologic processes during antigen presentation in HIV entry | Pérez-Martínez et al. (2010), Gordón-Alonso et al. (2013) | |
Co-IP | HEK293T and | N-terminus positively regulates interaction whereas the C-terminus seems to negatively regulate it | ||||||
FRET | HIV-infected T cells | |||||||
CD164 | Co-IP | Jurkat and | NA | Only induced when CXCL12 is presented on fibronectin | NA | CD164 participates to the CXCL12 mediated AKT and PKC-ζ phosphorylation | Forde et al. (2007), Huang et al. (2013) | |
Colocalization | Ovarian surface epithelial cells | |||||||
mDIA2 | Co-IP | MDA-MB-231 cells | NA | Constitutive (very weak) and CXCL12 induced | NA | Cytoskeletal rearrangement necessary for nonapoptotic blebbing | Wyse et al. (2017) | |
Colocalization | ||||||||
ATP13A2 | MYTH | Yeast | YES | Constitutive | NA | NA | Usenovic et al. (2012) | |
PI3Kγ | Co-IP | Human myeloid cells | NA | Only CXCL12 induced | NA | Integrin activation and chemotaxis | Schmid et al. (2011) | |
PECAM-1 | PLA | Human coronary artery endothelial cells | NO | Constitutive Induction not studied | NA | CXCR4 part of a junctional mechano-sensitive complex | dela Paz et al. (2014) | |
MYBL2 | 2HY | Yeast | Yes | NA | NA | NA | Wang et al. (2011) | |
KCNK1 | Co-IP | HeLa cells | NA | NA | NA | NA | Hein et al. (2015) | |
TMEM63B | Co-IP | HeLa cells | NA | NA | NA | NA | Hein et al. (2015) | |
GOLT1B | Co-IP | HeLa cells | NA | NA | NA | NA | Hein et al. (2015) | |
eIFB2 | Co-IP | Pre-B NALM6 cells | NA | Constitutive and negatively regulated by CXCL12 | NA | NA | Palmesino et al. (2016) | |
Colocalization | ||||||||
CDC73 | Co-IP | Pre-B NALM6 cells | NA | Constitutive Induction not studied | NA | NA | Palmesino et al. (2016) | |
CTR9 | Co-IP | Pre-B NALM6 cells | NA | Constitutive Induction not studied | NA | NA | Palmesino et al. (2016) | |
PAF1 | Co-IP | Pre-B NALM6 cells | NA | Constitutive Induction not studied | NA | NA | Palmesino et al. (2016) | |
NPM | Co-IP | Pre-B NALM6 cells | NA | Constitutive Induction not studied | NA | NA | Palmesino et al. (2016) | |
CD11B | Co-IP | Pre-B NALM6 cells | NA | Constitutive Induction not studied | NA | NA | Palmesino et al. (2016) | |
PTPRS | Co-IP | Pre-B NALM6 cells | NA | Constitutive Induction not studied | NA | NA | Palmesino et al. (2016) | |
LGALS8 | Co-IP | Pre-B NALM6 cells | NA | Constitutive Induction not studied | NA | NA | Palmesino et al. (2016) | |
ACKR3-interacting proteins | ||||||||
EGFR | PLA | MCF7 cells, breast cancer tissues, CaP cells | Mediated by β-arrestin2 | Interaction constitutive and induced by the epidermal growth factor. | NA | ACKR3 mediates phosphorylation of EGFR at tyrosine1110 after EGF-stimulation and phosphorylation of ERK1/2 with consequences on tumor proliferation. | Singh and Lokeshwar (2011), Salazar et al. (2014), Kallifatidis et al. (2016) | |
Colocalization | ||||||||
Co-IP | ||||||||
CD74 | Co-IP | NIH/3T3 cells and human B cells | NA | Constitutive, induction not investigated. | NA | ACKR3 is involved in MIF-mediated ERK-1/2 and ζ-chain-associated protein kinase activation in addition to MIF-mediated chemotaxis. | Alampour-Rajabi et al. (2015) | |
Colocalization | ||||||||
PLA | ||||||||
PECAM-1 | PLA | HCAECs cells | NA | Constitutive | NA | NA | dela Paz et al. (2014) | |
ATP13A2 | MYTH | Yeast | Yes | NA | NA | NA | Usenovic et al. (2012) | |
GJB2 | Co-IP | HeLa cells | NA | NA | NA | NA | Hein et al. (2015) | |
MRPL4 | Co-IP | HeLa cells | NA | NA | NA | NA | Hein et al. (2015) | |
ATP5H | Co-IP | HeLa cells | NA | NA | NA | NA | Hein et al. (2015) | |
ATP5B | Co-IP | HeLa cells | NA | NA | NA | NA | Hein et al. (2015) | |
ATP5A1 | Co-IP | HeLa cells | NA | NA | NA | NA | Hein et al. (2015) | |
ATP5O | Co-IP | HeLa cells | NA | NA | NA | NA | Hein et al. (2015) | |
ACKR3 | Co-IP | HeLa cells | NA | NA | NA | NA | Hein et al. (2015) | |
ESPL1 | Co-IP | HeLa cells | NA | NA | NA | NA | Hein et al. (2015) | |
HECTD2 | Co-IP | HeLa cells | NA | NA | NA | NA | Hein et al. (2015) | |
UBR7 | Co-IP | HeLa cells | NA | NA | NA | NA | Hein et al. (2015) |
ATP13A2, cation-transporting ATPase 13A2; ATP5H/ATP5B/ATP5A1/ATP5O, ATP synthase subunit d/beta/alpha/O, mitochondrial; CAP, human prostate cancer cells; CD11B, cyclin-dependent kinase 11B; CD164, endolyn; CDC73, parafibromin; CTR9, SH2 domain binding protein; eIF2B, eukaryotic translation initiation factor 2B; EGFR, epidermal growth factor receptor; ESPL1, HCAEC, Human Coronary Artery Endothelial Cells; HECTD2, probable E3 ubiquitin-protein ligase; GJB2, gap junction β-2 protein; GOLT1B, vesicle transport protein GOT1B; KCNK1, potassium channel subfamily K member 1; LGALS8, galectin; mDIA2, diaphanous-related formin-2; MYBL2, myb-related protein B; MRPL4, 54S ribosomal protein L4, mitochondrial; MYTH, membrane yeast two-hybrid assay; NA, not applicable; NF, nuclear factor; NMMHC, motor protein nonmuscle myosin H chain; NPM, nucleophosmin; PAF1, hypothetical protein PD2; PECAM-1, platelet endothelial cell adhesion molecule; PI3Kγ, PI3-kinase isoform p110γ; PLA, proximity ligation assay; PTPRS, receptor-type tyrosine-protein phosphatase S; RTN3, reticulon3; TLR2, Toll-like receptor 2; TMEM63B, CSC1-like protein 2; UBR7, putative E3 ubiquitin-protein ligase; Y2H, yeast two-hybrid assay.